Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 6, Issue 1, Pages e1585-e1585
Publisher
Springer Nature
Online
2015-01-08
DOI
10.1038/cddis.2014.545
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer
- (2014) Pratima Nangia-Makker et al. PLoS One
- Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma
- (2014) Francesco Gatto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-suppressivemicroRNA-143/145cluster targets hexokinase-2 in renal cell carcinoma
- (2013) Hirofumi Yoshino et al. CANCER SCIENCE
- Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle
- (2013) S. M. Hadad et al. Clinical & Translational Oncology
- Targeting angiogenesis in renal cell carcinoma
- (2013) Edwin M Posadas et al. EXPERT OPINION ON PHARMACOTHERAPY
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase
- (2012) Clara Rodrigues-Ferreira et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- 3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective “small molecule” anti-cancer agent taken from labside to bedside: introduction to a special issue
- (2012) Peter L. Pedersen JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
- (2012) Kivanç Birsoy et al. NATURE GENETICS
- An overview of renal cell cancer: Pathology and genetics
- (2012) Holger Moch SEMINARS IN CANCER BIOLOGY
- Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition
- (2011) Anna-Karin Boström et al. HUMAN PATHOLOGY
- Misdiagnosis of clear cell renal cell carcinoma
- (2011) Vladimir A. Valera et al. Nature Reviews Urology
- Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft
- (2011) Jun Liu et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma
- (2010) Huiqing Liu et al. BMC Systems Biology
- Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent
- (2009) P. Dell'Antone Medicinal Chemistry
- Regulation of endocytosis via the oxygen-sensing pathway
- (2009) Yi Wang et al. NATURE MEDICINE
- Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate1
- (2008) Ana Paula Pereira Da Silva et al. BIOCHEMICAL JOURNAL
- Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo
- (2008) Jonas Sjölund et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More